Evidence map›Paper›PMID 29524016›Full record

ArticleJournal of autism and developmental disorders2018

Prevalence of Co-occurring Medical and Behavioral Conditions/Symptoms Among 4- and 8-Year-Old Children with Autism Spectrum Disorder in Selected Areas of the United States in 2010.

G N Soke, M J Maenner, D Christensen, M Kurzius-Spencer, L A Schieve

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05916339 (Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder), which is not on this map. Cited by 106 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 4 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05916339 phase4recruitingnot on this mapstarted 2023, after this paper: background citation

Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder

TypeinterventionalSponsorDaniel CouryRan2023 to 2027Enrolled500ConditionsADHD, Autism Spectrum DisorderArmsRandomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 4 syntheses or guidelines pooled it, 198 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

G N SokeEpidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, GA, USA. yxo2@cdc.gov.
M J MaennerNational Center on Birth Defects and Developmental Disabilities/Division of Congenital and Developmental Disorders/Developmental Disabilities Branch, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS E-86, Atlanta, GA, 30341, USA.
D ChristensenNational Center on Birth Defects and Developmental Disabilities/Division of Congenital and Developmental Disorders/Developmental Disabilities Branch, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS E-86, Atlanta, GA, 30341, USA.
M Kurzius-SpencerDepartment of Pediatrics, Genetics and Developmental Pediatrics, University of Arizona College of Medicine, Tucson, AZ, USA.
L A SchieveNational Center on Birth Defects and Developmental Disabilities/Division of Congenital and Developmental Disorders/Developmental Disabilities Branch, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS E-86, Atlanta, GA, 30341, USA.
National Center on Birth Defects and Developmental Disabilities · USCenters for Disease Control and Prevention · USEpidemic Intelligence Service · USUniversity of Arizona · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

We compared the prevalence of various medical and behavioral co-occurring conditions/symptoms between 4- and 8-year-olds with autism spectrum disorder (ASD) from five sites in the Autism and Developmental Disabilities Monitoring Network during the 2010 survey year, accounting for sociodemographic differences. Over 95% of children had at least one co-occurring condition/symptom. Overall, the prevalence was higher in 8- than 4-year-olds for 67% of co-occurring conditions/symptoms examined. Further, our data suggested that co-occurring conditions/symptoms increased or decreased the age at which children were first evaluated for ASD. Similarly, among the 8-year-olds, the prevalence of most co-occurring conditions/symptoms was higher in children with a previous ASD diagnosis documented in their records. These findings are informative for understanding and screening co-occurring conditions/symptoms in ASD.

Indexed as

Population SurveillanceAutism Spectrum DisorderBehavioral SymptomsChildChild, PreschoolComorbidityDevelopmental DisabilitiesFemaleHumansMalePrevalenceSurveys and QuestionnairesUnited StatesAutismAutism spectrum disorderComorbid conditionsCo-occurring conditionsPrevalence

Identifiers

PMID29524016
PMCPMC6041136
OpenAlexW2790761228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.